{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:18:18Z","timestamp":1788311898306,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16398-0","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T07:22:12Z","timestamp":1782112932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is active surveillance of CIN2 always appropriate? Clinical outcomes and factors associated with progression and regression over 48 months in an HPV-positive cohort"],"prefix":"10.1186","volume":"26","author":[{"given":"Maria Teresa","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pagana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pivetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino Giovanni","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Tarascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Marzio","family":"Panella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"16398_CR1","doi-asserted-by":"crossref","unstructured":"Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M2019 ASCCP Risk-Based Management Consensus Guidelines Committee. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102\u201331.","DOI":"10.1097\/LGT.0000000000000525"},{"key":"16398_CR2","doi-asserted-by":"publisher","first-page":"k499","DOI":"10.1136\/bmj.k499","volume":"360","author":"K Tainio","year":"2018","unstructured":"Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, C\u00e1rdenas J, Hern\u00e1ndes, Glazer-Livson S, Jakobsson M, Joronen K, Kiviharju M, Louvanto K, Oksjoki S, T\u00e4htinen R, Virtanen S, Nieminen P, Kyrgiou M, Kalliala I. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018;360:k499. https:\/\/doi.org\/10.1136\/bmj.k499 . PMID: 29487049; PMCID: PMC5826010.","journal-title":"BMJ"},{"key":"16398_CR3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/ijgc-2019-000343","volume":"29","author":"MM Koeneman","year":"2019","unstructured":"Koeneman MM, Hendriks N, Kooreman LF, Winkens B, Kruitwagen RF, Kruse AJ. Prognostic factors for spontaneous regression of high-risk human papillomavirus-positive cervical intra-epithelial neoplasia grade 2. Int J Gynecol Cancer. 2019;29:1003\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"16398_CR4","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1016\/S1470-2045(24)00524-2","volume":"26","author":"M Kyrgiou","year":"2025","unstructured":"Kyrgiou M, Bowden SJ, Ellis LB, Hammer A, Lyons D, Freeman-Wang T, Kechagias KS, Kalliala I, Preti M, Kesic V, et al. Active surveillance of cervical intraepithelial neoplasia grade 2: 2025 British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology consensus statement. Lancet Oncol. 2025;26:e140\u201351.","journal-title":"Lancet Oncol"},{"key":"16398_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/1471-0528.16081","volume":"127","author":"M Skorstengaard","year":"2020","unstructured":"Skorstengaard M, Lynge E, Suhr J, Napolitano G. Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study. Int J Obstet Gynaecol. 2020;127:729\u201336.","journal-title":"Int J Obstet Gynaecol"},{"key":"16398_CR6","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.3390\/diagnostics15192512","volume":"15","author":"MT Bruno","year":"2025","unstructured":"Bruno MT, Pagana A, Lo Giudice C, Panella MM, Mascellino G, Lagan\u00e0 AS. CIN2 in the era of risk-based management and HPV vaccination: epidemiology, natural history and guidelines. Diagnostics. 2025;15:2512.","journal-title":"Diagnostics"},{"key":"16398_CR7","doi-asserted-by":"publisher","first-page":"i3633","DOI":"10.1136\/bmj.i3633","volume":"354","author":"M Kyrgiou","year":"2016","unstructured":"Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, Arbyn M, Bennett P, Paraskevaidis E. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016;354:i3633. https:\/\/doi.org\/10.1136\/bmj.i3633 . PMID: 27469988; PMCID: PMC4964801.","journal-title":"BMJ"},{"key":"16398_CR8","doi-asserted-by":"publisher","first-page":"a1284","DOI":"10.1136\/bmj.a1284","volume":"337","author":"M Arbyn","year":"2008","unstructured":"Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, Prendiville W, Paraskevaidis E. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ. 2008;337:a1284. https:\/\/doi.org\/10.1136\/bmj.a1284. PMID: 18801868; PMCID: PMC2544379.","journal-title":"BMJ"},{"key":"16398_CR9","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/AOG.0000000000000174","volume":"123","author":"SN Conner","year":"2014","unstructured":"Conner SN, Frey HA, Cahill AGM, Macones GAM, Colditz GAM, Tuuli MG. Loop electrosurgical excision procedure and risk of preterm birth. Obstet Gynecol. 2014;123:752\u201361.","journal-title":"Obstet Gynecol"},{"key":"16398_CR10","doi-asserted-by":"publisher","first-page":"e075925","DOI":"10.1136\/bmj-2023-075925","volume":"383","author":"KD Lycke","year":"2023","unstructured":"Lycke KD, Kahlert J, Petersen LK, Damgaard RK, Cheung LC, Gravitt PE, Hammer A. Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: Population based cohort study. BMJ. 2023;383:e075925.","journal-title":"BMJ"},{"issue":"2","key":"16398_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/LGT.0000000000000529","volume":"24","author":"D Egemen","year":"2020","unstructured":"Egemen D, Cheung LC, Chen X, Demarco M, Perkins RB, Kinney W, Poitras N, Befano B, Locke A, Guido RS, Wiser AL, Gage JC, Katki HA, Wentzensen N, Castle PE, Schiffman M, Lorey TS. Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines. J Low Genit Tract Dis. 2020;24(2):132\u201343. PMID: 32243308; PMCID: PMC7147417.","journal-title":"J Low Genit Tract Dis"},{"key":"16398_CR12","doi-asserted-by":"publisher","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890\u2013907. https:\/\/doi.org\/10.1016\/S0140-6736(07)61416-0. PMID: 17826171.","DOI":"10.1016\/S0140-6736(07)61416-0"},{"issue":"Suppl 1","key":"16398_CR13","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1097\/LGT.0b013e3182854253","volume":"17","author":"HA Katki","year":"2013","unstructured":"Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 3\u2009+\u2009and cervical cancer among women with HPV testing of ASC-US Pap results. J Low Genit Tract Dis. 2013;17(Suppl 1):S36\u201342.","journal-title":"J Low Genit Tract Dis"},{"key":"16398_CR14","unstructured":"Bruno MT, Ferrara M, Fava V, Barrasso G, Sapia F, Cutello S, Panella M. September prevalence genotypes and distribution of human papillomavirus infection in women with abnormal cervical cytology in Catania, Italy. Available online: https:\/\/www.researchgate.net\/publication\/317803848_Prevalence_genotypes_and_distribution_of_human_papillomavirus_infection_in_women_with_abnormal_cervical_cytology_in_Catania_Italy. Accessed on 16 2025."},{"key":"16398_CR15","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.5858\/1543-2165-137.6.738","volume":"136","author":"TM Darragh","year":"2012","unstructured":"Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med. 2012;136:1266\u201397. . Erratum in Arch. Pathol. Lab. Med. 2013, 137, 738. https:\/\/doi.org\/10.5858\/1543-2165-137.6.738. Erratum in Arch. Pathol. Lab. Med. 2013, 137, 738.","journal-title":"Arch Pathol Lab Med"},{"issue":"14","key":"16398_CR16","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/dji187","volume":"97","author":"MJ Khan","year":"2005","unstructured":"Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97(14):1072\u20139. https:\/\/doi.org\/10.1093\/jnci\/dji187 . PMID: 16030305.","journal-title":"J Natl Cancer Inst"},{"key":"16398_CR17","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3390\/cancers16112043","volume":"16","author":"MT Bruno","year":"2024","unstructured":"Bruno MT, Panella MM, Valenti G, Ruggeri Z, Sgalambro F, Reina S, Mereu L. Cervical Intraepithelial Neoplasia Grade 3 (CIN3) in Women Younger than 30 Years Was Significantly Associated with HPV16\/18 Genotypes. Cancers. 2024;16:2043. https:\/\/doi.org\/10.3390\/cancers16112043.","journal-title":"Cancers"},{"key":"16398_CR18","doi-asserted-by":"publisher","unstructured":"ASCUS-LSIL Traige Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol. 2003;188(6):1393\u2009\u2013\u2009400. https:\/\/doi.org\/10.1067\/mob.2003.462. PMID: 12824968.","DOI":"10.1067\/mob.2003.462"},{"key":"16398_CR19","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","volume":"285","author":"MH Stoler","year":"2001","unstructured":"Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations realistic estimates from the ASCUS-LSIL triage study. JAMA. 2001;285:1500\u20135.","journal-title":"JAMA"},{"key":"16398_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","volume":"12","author":"AG Ost\u00f6r","year":"1993","unstructured":"Ost\u00f6r AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12:186\u201392.","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"16398_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ajog.2024.01.029","volume":"230","author":"RK Damgaard","year":"2024","unstructured":"Damgaard RK, Jenkins D, Stoler MH, de Koning M, van de Sandt M, Lycke KD, Kahlert J, Gravitt PE, Quint WGV, Steiniche T, Petersen LK, Hammer A. Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2. Am J Obstet Gynecol. 2024;230(6):655. e1-655.e10. Epub 2024 Feb 7. PMID: 38336125.","journal-title":"Am J Obstet Gynecol"},{"key":"16398_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","volume":"33","author":"D Cibula","year":"2023","unstructured":"Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, Felix A, Fischerov\u00e1 D, Jahnn-Kuch D, Joly F, Kohler C, et al. ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer\u2014Update 2023. Int J Gynecol Cancer. 2023;33:649\u201366.","journal-title":"Int J Gynecol Cancer"},{"key":"16398_CR23","unstructured":"National Institute for Health and Care Excellence (NICE). Suspected Cancer: Recognition and Referral. NICE Guideline [NG12]. Updated 2025. Available online: https:\/\/www.nice.org.uk\/guidance\/ng12. Accessed on 16 September 2025."},{"issue":"7629","key":"16398_CR24","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/bmj.39363.471806.BE","volume":"335","author":"B Strander","year":"2007","unstructured":"Strander B, Andersson-Ellstr\u00f6m A, Milsom I, Spar\u00e9n P. Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ. 2007;335(7629):1077. https:\/\/doi.org\/10.1136\/bmj.39363.471806.BE . Epub 2007 Oct 24. PMID: 17959735; PMCID: PMC2094166.","journal-title":"BMJ"},{"key":"16398_CR25","doi-asserted-by":"publisher","first-page":"e6855","DOI":"10.1136\/bmj.e6855","volume":"345","author":"M Rebolj","year":"2012","unstructured":"Rebolj M, Helmerhorst T, Habbema D, Looman C, Boer R, van Rosmalen J, van Ballegooijen M. Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study. BMJ. 2012;345:e6855. https:\/\/doi.org\/10.1136\/bmj.e6855 . PMID: 23117059; PMCID: PMC3487103.","journal-title":"BMJ"},{"issue":"19","key":"16398_CR26","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/jnci\/djq356","volume":"102","author":"SK Kj\u00e6r","year":"2010","unstructured":"Kj\u00e6r SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010;102(19):1478\u201388. https:\/\/doi.org\/10.1093\/jnci\/djq356 . Epub 2010 Sep 14. PMID: 20841605; PMCID: PMC2950170.","journal-title":"J Natl Cancer Inst"},{"key":"16398_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12985-022-01822-1","volume":"19","author":"MT Bruno","year":"2022","unstructured":"Bruno MT, Cassaro N, Vitale SG, et al. Possible role of negative human papillomavirus E6\/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women. Virol J. 2022;19:95. https:\/\/doi.org\/10.1186\/s12985-022-01822-1.","journal-title":"Virol J"},{"key":"16398_CR28","doi-asserted-by":"publisher","first-page":"djv257","DOI":"10.1093\/jnci\/djv257","volume":"107","author":"N Wentzensen","year":"2015","unstructured":"Wentzensen N, Fetterman B, Castle PE, Schiffman M, Wood SN, Stiemerling E, Tokugawa D, Bodelon C, Poitras N, Lorey T, et al. p16\/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women. J Natl Cancer Inst. 2015;107:djv257.","journal-title":"J Natl Cancer Inst"},{"key":"16398_CR29","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.3390\/cancers15174203","volume":"15","author":"MT Bruno","year":"2023","unstructured":"Bruno MT, Bonanno G, Sgalambro F, Cavallaro A, Boemi S. Overexpression of E6\/E7 mRNA HPV Is a Prognostic Biomarker for Residual Disease Progression in Women Undergoing LEEP for Cervical Intraepithelial Neoplasia 3. Cancers. 2023;15:4203. https:\/\/doi.org\/10.3390\/cancers15174203.","journal-title":"Cancers"},{"key":"16398_CR30","doi-asserted-by":"publisher","unstructured":"Clarke MA, Wentzensen N, Perkins RB, Garcia F, Arrindell D, Chelmow D, Cheung LC, Darragh TM, Egemen D, Guido R et al. Recommendations for Use of p16\/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus. J. Low. Genit. Tract Dis. 2024, 28, 124\u2013130, Erratum in J. Low. Genit. Tract Dis. 2024;28:316. https:\/\/doi.org\/10.1097\/LGT.0000000000000825.","DOI":"10.1097\/LGT.0000000000000825"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16398-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16398-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16398-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:10:08Z","timestamp":1788311408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16398-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16398"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16398-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study conforms to the principles of the Declaration of Helsinki, as revised in 2013. Based on Italian law, the University Hospital\u2019s ethics committee (Catania 2), Azienda Ospedaliero-Universitaria Policlinico Rodolico\u2013San Marco, Catania, Italy, waived the requirement for ethical approval and informed consent because the study used previously archived data, according to current legislation (20 March 2008) (AIFA):\n                      \n                      (accessed on 12 December 2025).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1040"}}